No takes yet. Share an insight, caveat, or question.
National analysis reveals no survival difference for primary effusion lymphoma patients treated at academic or community cancer programs, indicating treatment disparities.
Reyes-Uribe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: